7株牛源A型巴氏杆菌的分离鉴定及耐药性分析

对2014年沈阳地区患有呼吸系统疾病的育肥牛场进行病原分离,得到7株分离菌,对其进行培养形态及染色观察、病理组织切片观察、动物致病性观察及16S序列分析,初步鉴定为牛多杀性巴氏杆菌(Pm)。利用Pm种特异性引物及荚膜血清特异性引物进行PCR扩增,均得到目的基因条带。对分离菌进行药敏试验的结果显示,5株分离菌株已对阿米卡星、新诺明产生较强耐药性;7株分离菌均对氟苯尼考、恩诺沙星、四环素及氨苄西林敏感。由此确定,分离菌株均为牛荚膜A型巴氏杆菌,且已具有一定耐药性。     

膜分离法纯化浓缩的猪细小病毒灭活疫苗效果研究

为了研究纯化浓缩的猪细小病毒灭活疫苗的免疫效果,应用微滤/超滤管式陶瓷膜分离系统对猪细小病毒细胞收获液进行纯化浓缩,使浓缩液病毒平均含量由10~(4.7)TCID_(50)/mL提高到10~(6.5)TCID_(50)/mL;将纯化浓缩的病毒液经检验合格后,进行甲醛灭活,与注射用矿物白油佐剂制成油包水灭活疫苗;按照猪细小病毒灭活疫苗的质量标准,对制备的灭活疫苗进行检验与免疫效果试验。结果显示:纯化浓缩的猪细小病毒液杂蛋白去除率平均达到71.6%左右;制备的三组灭活疫苗检验均合格;免疫至63 d时,免疫猪体内抗猪细小病毒抗体(HI)水平分别为:纯化浓缩的灭活疫苗平均高达9.62 log_2稀释倍数,常规疫苗平均为8.78log_2稀释倍数,差异显著(P0.05)。试验表明:疫苗病毒细胞收获液进行膜纯化技术处理后,免疫效果显著优于未经纯化的常规灭活疫苗。     

RP-HPLC测定木槟硝黄散中木香烃内酯、去氢木香内酯的含量

建立了RP-HPLC法测定木槟硝黄散中木香烃内酯与去氢木香内酯含量的方法。用十八烷基键合硅胶柱分离木槟硝黄散中木香烃内酯与去氢木香内酯,以甲醇-水(60∶40)为流动相,检测波长225 nm。木槟硝黄散中木香烃内酯与去氢木香内酯的线性范围分别为4.14~41.4μg/m L和3.59~35.9μg/m L,平均回收率分别为99.23%、99.00%(n=6)。该方法简便、快速,可用于木槟硝黄散中木香烃内酯与去氢木香内酯的含量测定。     

蚕沙和稻秸不同比例组合对瘤胃微生物体外发酵的组合效应

本文采用瘤胃微生物体外发酵法研究了不同比例蚕沙(SE)和稻秸(RS)的组合效应。试验将SE:RS设计为100∶0(SE100组)、80∶20(SE80组)、60∶40(SE60组)、40∶60(SE40组)、20∶80(SE20组)、0∶100(SE0组)的比例,分别进行体外发酵批次培养24 h和体外发酵产气培养72 h,测定产气参数和发酵特性指标。结果表明:1)SE100组理论最大产气量显著高于其他各组(P<0.05),SE80组的24和72 h累积产气量显著高于其他组(P<0.05)。2)24 h时培养液总挥发性脂肪酸浓度为SE80组>SE100组>SE60组>SE40组>SE0组>SE20组,乙酸/丙酸为SE80组SE100组>SE60组>SE80组>SE40组>SE0组。4)随着蚕沙比例的升高,底物体外有机物消化率越高。5)SE80组多项指标组合效应指数为0.76,SE80组>SE40组>SE60组>SE20组。蚕沙和稻秸组合改善了体外瘤胃微生物发酵特性和产气参数,且蚕沙和稻秸的最佳比例为80∶20。     

饲料脂肪源和乳化剂对牛蛙生长性能、肠道消化酶活力及肝脏生化指标的影响

本试验旨在研究以猪油或鱼油为脂肪源的饲料中添加乳化剂对牛蛙生长性能、肠道消化酶活力及肝脏生化指标的影响。试验采用2×2因子完全随机区组试验设计,2种脂肪源(猪油和鱼油)和2个乳化剂添加水平(0和300 mg/kg),配成4种等氮等能的试验饲料。将初始平均体重为(19.01±0.01)g的180只牛蛙随机分为4组,每组3个重复,每个重复15只蛙,进行为期8周的饲养试验。结果表明:未添加乳化剂的鱼油组增重率(WGR)和摄食量(FI)显著高于未添加乳化剂的猪油组(P0.05)。添加乳化剂的猪油组WGR和FI显著高于添加乳化剂的鱼油组(P0.05)。添加乳化剂的猪油组WGR、FI和特定生长率(SGR)显著高于未添加乳化剂的猪油组(P0.05),2组之间饲料系数(FCR)、氮沉积率(NRE)、能量沉积率(ERE)均差异不显著(P0.05)。添加乳化剂的鱼油组的各生长性能指标与未添加乳化剂的鱼油组均无显著差异(P0.05)。各组牛蛙胴体水分、粗蛋白质、粗脂肪和粗灰分含量差异不显著(P0.05),而添加乳化剂的猪油组全体粗脂肪含量显著高于未添加乳化剂的猪油组(P0.05)。各组牛蛙肠道蛋白酶和淀粉酶活力差异不显著(P0.05),饲料中添加乳化剂显著提高以猪油为主要脂肪源牛蛙的肠道脂肪酶活力(P0.05),而对以鱼油为主要脂肪源牛蛙的影响不显著(P0.05)。各组牛蛙肝脏过氧化氢酶(CAT)和超氧化物歧化酶(SOD)活力无显著差异(P0.05)。在以猪油为主要脂肪源时,添加乳化剂显著提高肝脏丙二醛(MDA)含量(P0.05);在以鱼油为主要脂肪源时,添加乳化剂对肝脏MDA含量无显著影响(P0.05)。根据结果得出,在以猪油为主要脂肪源的饲料中添加乳化剂可提高牛蛙的生长性能。     

Prevalence of thermophilic Campylobacter species in Swedish dogs and characterization of C. jejuni isolates

Background

The aims of this study were to investigate the prevalence of Campylobacter species in Swedish dogs, to identify the species of the Campylobacter isolates and to genotype the C. jejuni isolates. Young and healthy dogs were targeted and the sampling was performed at 11 veterinary clinics throughout Sweden from October 2011 to October 2012. Faecal swab samples were collected and sent to the laboratory at the National Veterinary Institute (SVA) for isolation of Campylobacter, speciation and genotyping.

Results

Campylobacter spp. were isolated from 67 of the 180 sampled dogs which yields an overall prevalence of 37%. The most prevalent species of Campylobacter among the participating dogs was C. upsaliensis with 52 of the 67 identified isolates. A lower prevalence was observed for C. jejuni with seven identified isolates and one isolate was identified as C. helveticus. Multi-locus sequence typing (MLST) was carried out on the seven C. jejuni isolates and all sequence types that were found are also commonly found in humans. The dogs were divided into three age groups; 1) under 12 months, 2) 12 to 23 months and 3) 24 months and older. The highest prevalence was found in the two younger age groups. Dogs shedding C. jejuni were between 3–12 months of age while dogs shedding C. upsaliensis were found in all ages.

Conclusions

The present investigation finds that Campylobacter spp. known to cause campylobacteriosis in humans are present in Swedish dogs. The results suggest an age predisposition where dogs under 2 years of age are more likely to shed Campylobacter spp. than older dogs. The most commonly isolated species was C. upsaliensis followed by C. jejuni, which was only detected in dogs up to 12 months of age. All C. jejuni isolates identified in the present study were of the same MLST types that have previously been described both in humans and in animals. The awareness of the Campylobacter risk of healthy young dogs may be an important way to reduce the transmission from dogs to infants, young children and immunocompromised adults.     

A KCNJ10 mutation previously identified in the Russell group of terriers also occurs in Smooth-Haired Fox Terriers with hereditary ataxia and in related breeds

Background

Hereditary ataxias with similar phenotypes were reported in the Smooth-Haired Fox Terrier, the Jack Russell Terrier and the Parson Russell Terrier. However, segregation analyses showed differing inheritance modes in these breeds. Recently, molecular genetic studies on the Russell group of terriers found independent mutations in KCNJ10 and CAPN1, each associated with a specific clinical subtype of inherited ataxia. The aim of this study was to clarify whether or not Smooth-Haired Fox Terriers with hereditary ataxia and dogs of other related breeds harbor either of the same mutations. A sub goal was to update the results of KCNJ10 genotyping in Russell group terriers.

Findings

Three Smooth-Haired Fox Terriers with hereditary ataxia and two Toy Fox Terriers with a similar phenotype were all homozygous for the KCNJ10 mutation. The same mutation was also found in a heterozygous state in clinically unaffected Tenterfield Terriers (n = 5) and, in agreement with previous studies, in Jack Russell Terriers, Parson Russell Terriers, and Russell Terriers.

Conclusions

A KCNJ10 mutation, previously associated with an autosomal recessive spinocerebellar ataxia in Jack Russell Terriers, Parson Russell Terriers, and Russell Terriers segregates in at least three more breeds descended from British hunting terriers. Ataxic members of two of these breeds, the Smooth-Haired Fox Terrier and the Toy Fox Terrier, were homozygous for the mutation, strengthening the likelihood that this genetic defect is indeed the causative mutation for the disease known as “hereditary ataxia” in Fox Terriers and “spinocerebellar ataxia with myokymia, seizures or both” in the Russell group of terriers.     

Seasonal patterns of gastrointestinal nematode infection in goats on two Lithuanian farms

Background

This study investigated seasonal changes in naturally acquired gastrointestinal nematode (GIN) infections on two Lithuanian goat farms with different parasite control practices.

Findings

On both farms, nematode faecal egg counts (FEC) and larval cultures were obtained from 15 adult and 10 young goats at bi-weekly intervals from April 2012 to April 2013. Goats on farm A were dewormed with ivermectin (0.3 mg/kg body weight) in October/November 2012, whereas the animals on farm B were left untreated. Thirteen young goats were slaughtered in August/November 2012 and April 2013 and worm burdens in the gastrointestinal tract were enumerated. In goats from both farms, Teladorsagia, Trichostrongylus, Oesophagostomum, Chabertia and Haemonchus were the dominant GIN genera. Herbage contamination with infective third-stage larvae (L₃) peaked in July/August and resulted in high FEC in September/October. Parasitological examination at slaughter showed that Teladorsagia spp. and Haemonchus contortus survived the winter, both in the abomasal mucosa as adults and as early fourth-stage larvae (EL₄). Deworming on farm A significantly reduced FEC, especially of H. contortus, at the start of the grazing period compared with the untreated farm B (P < 0.05).

Conclusions

Goats were heavily infected with several GIN throughout the year. Strategic anthelmintic treatment during housing significantly reduced nematode egg output, in particular by H. contortus, at the start of the grazing season.     

Sodium bicarbonate protects uranium-induced acute nephrotoxicity through uranium-decorporation by urinary alkalinization in rats

To evaluate the effectiveness of sodium bicarbonate (SB) in removing uranium and protecting animals from uranium toxicity, we intramuscularly administered 1 mg/kg of uranyl nitrate to 8-wk-old male SD rats, and 20 min after administration of uranyl nitrate, the animals were given a single oral administration of SB at 0.1, 0.3 or 1 g/kg. The SB treatment at a dose of 0.3 g/kg or more raised the pH of the rats’ urine until 4 h after treatment, and it significantly reduced the uranium amounts in the kidneys at 1 day after treatment. In another experiment, rats were intramuscularly administered 1 mg/kg of uranyl nitrate, and 20 min later, the animals were treated with sodium bicarbonate (0.1 or 1 g/kg). The rats were autopsied at 1, 3 and 7 days after uranium treatment. High-dose SB resulted in a significant increase in urinary uranium excretion in the first 24 h and a reduction of uranium deposition in the kidneys and femurs, and it also significantly suppressed uranium-induced renal toxicity, as shown by both histopathology and clinical chemistry at 3 days after uranium treatment. Low-dose SB did not show such marked effects. Our findings demonstrated that the uranium decorporation effect of sodium bicarbonate was observed at the dosage showing urine alkalinization in rats and that decorporation effect of sodium bicarbonate might be beneficial if it is administered immediately after incorporation of soluble uranium.     

Time course of the incidence/multiplicity and histopathological features of murine colonic dysplasia,adenoma and adenocarcinoma induced by benzo[a]pyrene and dextran sulfate sodium

Benzo[a]pyrene (BP) is mutagenic but noncarcinogenic in the murine colon. Recently, we reported rapid induction of colonic tumors by treatment of CD2F₁ mice with BP (125 mg/kg for 5 days) followed by a colitis inducer, dextran sulfate sodium (DSS) (4% in drinking water for 1 or 2 weeks). However, there are no reports on detailed time course and histopathological features of colonic proliferative lesions in this model. Here, we show the detailed time course of colonic dysplasia, adenoma and adenocarcinoma induced by treatment with BP, DSS, and a combination of the two (BP/DSS). In the colon of mice exposed to BP/DSS, 14.6 dysplastic foci per mouse were present one week after DSS treatment (week 4). The number of dysplastic foci decreased with time to 3.1 at week 9 and thereafter remained almost constant. At week 4, 1.5 adenocarcinomas were also observed, with a marked increase in numbers with time, reaching 29.3 at week 14. In contrast, the number of dysplastic foci induced by DSS alone showed a time course similar to that following BP/DSS treatment; however, only a few tumors appeared. Neither dysplastic foci nor neoplastic lesions were induced by BP only. In mice exposed to BP/DSS, β-catenin was demonstrated immunohistochemically in the nucleus and/or cytoplasm of the tumor cells, and this translocation from the cell membrane was evident in subsets of dysplastic foci. In dysplastic foci induced by DSS alone, β-catenin was absent in the nucleus/cytoplasm. These finding suggest that aberrant β-catenin accumulation in dysplastic foci is associated with tumor progression in this BP/DSS model.